A NOVEL LOW-DOSE COMBINATION DRUG THERAPY FOR ENDOMETRIOSIS THAT INCREASES PROGESTERONE RECEPTOR TO ENHANCE PROGESTIN EFFICACY
article
OA: bronze
CC0
AI-generated summary
This paper describes a new low-dose drug combination therapy for endometriosis that increases progesterone receptor expression to improve progestin treatment effectiveness.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (11)
- Can symptomatology help in the diagnosis of endometriosis? Findings from a national case–control study—Part 1 via openalex
- Changing trends in the diagnosis of endometriosis: A comparative study of women with pelvic endometriosis presenting with chronic pelvic pain or infertility via openalex
- Clinical diagnosis of endometriosis: a call to action via openalex
- Diagnostic Delay of Endometriosis in the Netherlands via openalex
- IMPACT OF ENDOMETRIOSIS ON SEXUAL LIFE OF WOMEN AND PARTNERS: RESULTS FROM THE ENDOVIE SURVEY via openalex
- Pointers to earlier diagnosis of endometriosis: a nested case-control study using primary care electronic health records via openalex
- Risk factors associated with endometriosis: importance of study population for characterizing disease in the ENDO Study via openalex
- Time elapsed from onset of symptoms to diagnosis of endometriosis in a cohort study of Brazilian women via openalex
- W2921518676 via openalex
- W6689135859 via openalex
- W6757289468 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK